DK1249450T3 - Benzimidazolderivater som human chymase-inhibitorer - Google Patents

Benzimidazolderivater som human chymase-inhibitorer

Info

Publication number
DK1249450T3
DK1249450T3 DK01901397T DK01901397T DK1249450T3 DK 1249450 T3 DK1249450 T3 DK 1249450T3 DK 01901397 T DK01901397 T DK 01901397T DK 01901397 T DK01901397 T DK 01901397T DK 1249450 T3 DK1249450 T3 DK 1249450T3
Authority
DK
Denmark
Prior art keywords
halo
optionally substituted
oxo
trihalomethyl
alk
Prior art date
Application number
DK01901397T
Other languages
Danish (da)
English (en)
Inventor
Naoki Tsuchiya
Yoshiyuki Matsumoto
Hiroshi Saitou
Tsuyoshi Mizuno
Original Assignee
Teijin Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Ltd filed Critical Teijin Pharma Ltd
Application granted granted Critical
Publication of DK1249450T3 publication Critical patent/DK1249450T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK01901397T 2000-01-17 2001-01-17 Benzimidazolderivater som human chymase-inhibitorer DK1249450T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000007533 2000-01-17
JP2000392303 2000-12-25
PCT/JP2001/000271 WO2001053291A1 (fr) 2000-01-17 2001-01-17 Derives benzimidazoles

Publications (1)

Publication Number Publication Date
DK1249450T3 true DK1249450T3 (da) 2008-02-11

Family

ID=26583615

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01901397T DK1249450T3 (da) 2000-01-17 2001-01-17 Benzimidazolderivater som human chymase-inhibitorer

Country Status (19)

Country Link
EP (1) EP1249450B1 (ko)
JP (1) JP4059671B2 (ko)
KR (2) KR100763779B1 (ko)
CN (2) CN1198819C (ko)
AT (1) ATE375156T1 (ko)
AU (2) AU777813B2 (ko)
CA (1) CA2396908A1 (ko)
CZ (1) CZ301504B6 (ko)
DE (1) DE60130865T2 (ko)
DK (1) DK1249450T3 (ko)
ES (1) ES2295128T3 (ko)
HK (1) HK1050009A1 (ko)
IL (1) IL150565A0 (ko)
NO (1) NO324049B1 (ko)
NZ (1) NZ520028A (ko)
PT (1) PT1249450E (ko)
RU (1) RU2263674C2 (ko)
SI (1) SI1249450T1 (ko)
WO (1) WO2001053291A1 (ko)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1362854E (pt) * 2001-02-22 2008-01-21 Teijin Pharma Ltd Derivados benzo[b]tiofeno e processos para o produzir
NZ523407A (en) 2001-05-07 2005-04-29 Teijin Ltd 3-Hydroxymethyl-benzo[b]thiophene derivatives and process for making the same
CN101433717A (zh) * 2001-08-24 2009-05-20 帝人株式会社 含有食糜酶抑制剂和ace抑制剂作为有效成分的药物
CL2004001034A1 (es) * 2003-05-14 2005-03-28 Teijin Pharma Ltd Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r
WO2005018672A1 (ja) * 2003-08-22 2005-03-03 Teijin Pharma Limited キマーゼ阻害剤を有効成分として含有する薬剤
US20080015240A1 (en) * 2004-11-12 2008-01-17 Mitsuru Teramoto Acid Salt of Benzimidazole Derivative and Crystal Thereof
WO2007021032A1 (ja) 2005-08-18 2007-02-22 Teijin Pharma Limited 正確な用量分割機能を有する製剤
US20090155361A1 (en) 2005-08-18 2009-06-18 Masahiko Narasaki Tablet with multiple drug-containing sections
RU2008121223A (ru) 2005-10-27 2009-12-10 Тейдзин Фарма Лимитед (Jp) Производные 3-гидроксиметилбензо[ь]тиофена и способ их получения
EP1947097A1 (en) 2005-10-27 2008-07-23 Teijin Pharma Limited BENZOÝb¨THIOPHEN DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF
PE20070698A1 (es) 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
UA95788C2 (en) * 2005-12-15 2011-09-12 Ф. Хоффманн-Ля Рош Аг Fused pyrrole derivatives
ATE518840T1 (de) 2007-05-22 2011-08-15 Boehringer Ingelheim Int Benzimidazolonchymasehemmer
TWI443090B (zh) * 2007-05-25 2014-07-01 Abbvie Deutschland 作為代謝性麩胺酸受體２（ｍｇｌｕ２ 受體）之正向調節劑之雜環化合物
WO2008153129A1 (ja) * 2007-06-14 2008-12-18 Teijin Pharma Limited 尿酸値低下剤
WO2009133964A1 (ja) * 2008-04-28 2009-11-05 国立大学法人九州大学 酸化ストレス抑制剤
WO2010030500A1 (en) * 2008-09-09 2010-03-18 Boehringer Ingelheim International Gmbh Aza-benzimidazolone chymase inhibitors
MX2011003239A (es) 2008-09-26 2011-04-28 Merck Sharp & Dohme Nuevos derivados de bencimidazol ciclicos utiles como agentes anti-diabeticos.
AU2009307884B2 (en) 2008-10-22 2014-07-31 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
MX2011004505A (es) 2008-10-29 2011-05-31 Merck Sharp & Dohme Derivados novedosos de bencimidazol ciclico, utiles como agentes antidiabeticos.
US8329914B2 (en) 2008-10-31 2012-12-11 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
AR079050A1 (es) * 2009-11-18 2011-12-21 Astrazeneca Ab Compuestos benzoimidazolicos y sus usos
US8895596B2 (en) 2010-02-25 2014-11-25 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
CN105001219A (zh) 2011-02-25 2015-10-28 默沙东公司 用作抗糖尿病药剂的新的环状氮杂苯并咪唑衍生物
TW201348199A (zh) * 2012-05-04 2013-12-01 Novartis Ag 補體路徑調節劑及其用途
KR20150036245A (ko) 2012-08-02 2015-04-07 머크 샤프 앤드 돔 코포레이션 항당뇨병 트리시클릭 화합물
EP2888007B1 (en) 2012-08-22 2019-09-18 Merck Sharp & Dohme Corp. Benzimidazole tetrahydrofuran derivatives useful as amp-activated protein kinase activators
US9382243B2 (en) 2012-08-22 2016-07-05 Merck Sharp & Dohme Corp. Azabenzimidazole tetrahydropyran derivatives
US9556193B2 (en) 2012-08-22 2017-01-31 Merck Shapr & Dohme Corp. Benzimidazole hexahydrofuro[3,2-b]furan derivatives
EP2888008B1 (en) 2012-08-22 2018-12-26 Merck Sharp & Dohme Corp. Novel azabenzimidazole tetrahydrofuran derivatives
WO2014031445A1 (en) 2012-08-22 2014-02-27 Merck Sharp & Dohme Corp. Novel benzimidazole tetrahydropyran derivatives
WO2014031515A1 (en) 2012-08-22 2014-02-27 Merck Sharp & Dohme Corp. Novel azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
EP2970119B1 (en) 2013-03-14 2021-11-03 Merck Sharp & Dohme Corp. Novel indole derivatives useful as anti-diabetic agents
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
US10519115B2 (en) 2013-11-15 2019-12-31 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
WO2015089809A1 (en) 2013-12-19 2015-06-25 Merck Sharp & Dohme Corp. Antidiabetic substituted heteroaryl compounds
CN111004125B (zh) * 2019-12-24 2022-11-22 东华理工大学 一种缩醛或缩酮化合物的制备方法
CN116903541B (zh) * 2023-08-14 2023-12-08 中国环境科学研究院 用于酚类污染物检测的酰基咪唑类化合物、制备方法及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430950A1 (fr) * 1978-07-10 1980-02-08 Delalande Sa Nouveaux derives heterocycliques de la benzimidazole, leur procede de preparation et leur application en therapeutique
DE2928055A1 (de) * 1978-07-12 1980-01-31 Eastman Kodak Co Verfahren zur verbesserung der widerstandsfaehigkeit von polyesterformkoerpern gegenueber einem abbau durch u.v.- licht
JPS62212386A (ja) * 1986-03-14 1987-09-18 Suntory Ltd ２−ピリジルメチルベンズイミダゾ−ル誘導体
JPH01265089A (ja) * 1988-04-15 1989-10-23 Zeria Pharmaceut Co Ltd 新規１−（イミダゾール−４−イル）メチルベンズイミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
GB9225141D0 (en) * 1992-12-01 1993-01-20 Smithkline Beecham Corp Chemical compounds
US5527597A (en) * 1995-03-01 1996-06-18 Southern Mills, Inc. Stretchable flame resistant fabric
WO1999026932A1 (en) * 1997-11-26 1999-06-03 Axys Pharmaceuticals, Inc. By amidino group substituted heterocyclic derivatives and their use as anticoagulants
WO2000003997A1 (fr) * 1998-07-15 2000-01-27 Teijin Limited Derives de thiobenzimidazole
KR100731273B1 (ko) * 1999-06-28 2007-06-21 얀센 파마슈티카 엔.브이. 호흡기 신시티움 바이러스 복제 억제제
CZ2001153A3 (cs) * 1999-07-14 2001-06-13 Teijin Ltd Thiobenzimidazolové deriváty

Also Published As

Publication number Publication date
NO20023415D0 (no) 2002-07-16
NO324049B1 (no) 2007-08-06
CN1680339A (zh) 2005-10-12
RU2263674C2 (ru) 2005-11-10
CZ301504B6 (cs) 2010-03-24
IL150565A0 (en) 2003-02-12
ATE375156T1 (de) 2007-10-15
CA2396908A1 (en) 2001-07-26
NZ520028A (en) 2004-07-30
AU2005200172B2 (en) 2007-08-23
RU2002122105A (ru) 2004-01-10
AU2005200172A1 (en) 2005-02-10
KR20020065929A (ko) 2002-08-14
NO20023415L (no) 2002-07-16
WO2001053291A1 (fr) 2001-07-26
DE60130865T2 (de) 2008-07-17
SI1249450T1 (sl) 2008-04-30
HK1050009A1 (en) 2003-06-06
PT1249450E (pt) 2008-01-02
EP1249450A1 (en) 2002-10-16
KR20070057276A (ko) 2007-06-04
CN1418211A (zh) 2003-05-14
DE60130865D1 (de) 2007-11-22
CN100415723C (zh) 2008-09-03
CN1198819C (zh) 2005-04-27
ES2295128T3 (es) 2008-04-16
JP4059671B2 (ja) 2008-03-12
AU2704901A (en) 2001-07-31
KR100763779B1 (ko) 2007-10-05
AU777813B2 (en) 2004-11-04
EP1249450B1 (en) 2007-10-10
EP1249450A4 (en) 2003-04-09

Similar Documents

Publication Publication Date Title
DK1249450T3 (da) Benzimidazolderivater som human chymase-inhibitorer
DE502004005959D1 (de) Pyrimidin-2-on-verbindungen und ihre verwendung als dopamin-d3-rezeptorliganden
HU0900587D0 (en) Stable salts of 3,3-diphenylpropylamines and preparation thereof
ATE540938T1 (de) Neue benzoxazinonderivate als langwirksame betamimetika zur behandlung von atemwegserkrankungen
RU2003136097A (ru) Производные фенилпиридинкарбонилпиперазина
ECSP055644A (es) Derivados de la quinolil-propil-piperidina y su utilización
DE69132713D1 (de) Benzylidenthiazolidinderivate, ihre Herstellung und ihre Anwendung als Lipidperoxid-Inhibitoren
NO20044041L (no) Okso-azabisykliske forbindelser
TW200504085A (en) Derivatives of [2-(8,9-dioxo-2, 6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of use thereof
ATE502936T1 (de) 2, 6-di-(hetero-)aryl-4-amido-pyrimidine als adenosin-rezeptor-antagonisten
JP2011510072A5 (ko)
CY1110465T1 (el) Υποκατεστημενα παραγωγα ιμιδαζολινης
NO20074622L (no) Metabolitter for NK-1 antagonister for brekninger
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
HK1080282A1 (en) Improved formulations containing substituted imidazole derivatives
ES2172436A1 (es) Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
KR950032194A (ko) 신규푸린유도체 및 그 약학적으로 허용되는 염
DE69414396D1 (de) Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten
JPH083044A (ja) 骨粗鬆症の予防または治療剤
AR035219A1 (es) Compuesto de 1, 2, 3, 4, 4a, 5, 6, 7, 8, 8 a-decahidroisoquinolina, su uso para preparar una composicion farmaceutica, dicha composicion farmaceutica y procedimiento para preparar dicho compuesto
DE69904427D1 (de) Benzothiophenderivate als antithrombotische Mitteln und Zwischenprodukte
HUP0204131A2 (hu) Szacharinszármazékok, mint orálisan aktív elasztáz inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények